Brief: Ascletis Pharma Says To Repurchase Shares To Use Up To HK$200 Mln In Funds
22/05/2023 13:11
May 22 (Reuters) - Ascletis Pharma Inc 1672.HK :
* BOARD HAS DECIDED TO REPURCHASE SHARES ON OPEN MARKET FROM
TIME
TO TIME TO USE UP TO HK$200 MILLION IN FUNDS
Further company coverage: 1672.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascletis Pharma
See all newsFactbox: Race to launch weight-loss pill heats up as Novo wins UK approval
Brief: Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
Factbox: Race to launch weight-loss pill heats up as Lilly wins US approval
Brief: Ascletis Pharma FY Loss Attributable Rmb359.9 Million
Brief: Ascletis Pharma Expects To Submit IND Application To U.S. FDA For ASC39 In Q3 2026